ConductScience.org, home
Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy
API referenceFor AI assistants

Trial · NCT05513937

Participant flow36

How many started, completed or left each group, period by period.

1 to 20 of 36

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Run in (-4 Week to 0) Monotherapy PhaseSTARTEDRun-In Nebivolol 5mg143
Run in (-4 Week to 0) Monotherapy PhaseSTARTEDRun-In Amlodipine 5mg158
Run in (-4 Week to 0) Monotherapy PhaseSTARTEDCombination Therapy Nebivolol 5mg/ Amlodipine 5mg0
Run in (-4 Week to 0) Monotherapy PhaseSTARTEDCombination Therapy Nebivolol 5mg/ Amlodipine 10mg0
Run in (-4 Week to 0) Monotherapy PhaseCOMPLETEDRun-In Nebivolol 5mg139
Run in (-4 Week to 0) Monotherapy PhaseCOMPLETEDRun-In Amlodipine 5mg152
Run in (-4 Week to 0) Monotherapy PhaseCOMPLETEDCombination Therapy Nebivolol 5mg/ Amlodipine 5mg0
Run in (-4 Week to 0) Monotherapy PhaseCOMPLETEDCombination Therapy Nebivolol 5mg/ Amlodipine 10mg0
Run in (-4 Week to 0) Monotherapy PhaseNOT COMPLETEDRun-In Nebivolol 5mg4
Run in (-4 Week to 0) Monotherapy PhaseNOT COMPLETEDRun-In Amlodipine 5mg6
Run in (-4 Week to 0) Monotherapy PhaseNOT COMPLETEDCombination Therapy Nebivolol 5mg/ Amlodipine 5mg0
Run in (-4 Week to 0) Monotherapy PhaseNOT COMPLETEDCombination Therapy Nebivolol 5mg/ Amlodipine 10mg0
Combination Therapy (0 to 4 Weeks)STARTEDRun-In Nebivolol 5mg0
Combination Therapy (0 to 4 Weeks)STARTEDRun-In Amlodipine 5mg0
Combination Therapy (0 to 4 Weeks)STARTEDCombination Therapy Nebivolol 5mg/ Amlodipine 5mg279
Combination Therapy (0 to 4 Weeks)STARTEDCombination Therapy Nebivolol 5mg/ Amlodipine 10mg0
Combination Therapy (0 to 4 Weeks)COMPLETEDRun-In Nebivolol 5mg0
Combination Therapy (0 to 4 Weeks)COMPLETEDRun-In Amlodipine 5mg0
Combination Therapy (0 to 4 Weeks)COMPLETEDCombination Therapy Nebivolol 5mg/ Amlodipine 5mg279
Combination Therapy (0 to 4 Weeks)COMPLETEDCombination Therapy Nebivolol 5mg/ Amlodipine 10mg0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05513937/flow

API referenceFor AI assistants